T
Teligent Inc (NEW JERSEY)
OTC:TLGTQ
Teligent Inc (NEW JERSEY)
OTC:TLGTQ
Price:
0.0002 USD
Market Closed
Updated:
May 7, 2024
Teligent Inc (NEW JERSEY)
Revenue
|
Teligent Inc (NEW JERSEY)
Revenue Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
T
|
Teligent Inc (NEW JERSEY)
OTC:TLGTQ
|
Revenue
$45.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$85.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$55.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$61.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$35.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
Teligent Inc (NEW JERSEY)
Revenue Breakdown
Breakdown by Geography
Teligent Inc (NEW JERSEY)
Teligent Inc (NEW JERSEY)
Not Available
Breakdown by Segments
Teligent Inc (NEW JERSEY)
Teligent Inc (NEW JERSEY)
|
Total Revenue:
45.3m
USD
|
|
Tropical Product Sales:
32.8m
USD
|
|
Injectables Product Sales:
10.9m
USD
|
|
Company Manufacturing Sales:
1.2m
USD
|
|
Research And Development Services And Other I...:
548k
USD
|
See Also
What is Teligent Inc (NEW JERSEY)'s Revenue?
Revenue
45.3m
USD
45.3m
USD
Based on the financial report for Dec 31, 2020, Teligent Inc (NEW JERSEY)'s Revenue amounts to 45.3m USD.
What is Teligent Inc (NEW JERSEY)'s Revenue growth rate?
Revenue CAGR 5Y
0%
0%
Over the last year, the Revenue growth was -31%. The average annual Revenue growth rates for Teligent Inc (NEW JERSEY) have been -9% over the past three years .
You don't have any saved screeners yet
